Kunal Kadakia is a Hematology physician affiliated with Atrium Health Wake Forest Baptist. OpenAlex indexes 107 publications with 1,288 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1021 Morehead Medical Dr
Ste A
Charlotte, NC 282042990
Telephone
980-442-2000Registry record last updated 15 Jul 2024.
Clinical trials
- Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
45.6%Opioid Agonist15.6%Oxycodone Hcl59%Morphine Sulfate Er41%Part D<11 patientsGabapentinoids11.3%Gabapentin67%Pregabalin33%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
30.3%Proton pump inhibitor11.6%Omeprazole50%Pantoprazole Sodium50%Part D<11 patientsSerotonin-3 Receptor Antagonist10%Ondansetron Hcl100%Part D≥17 patients+ 2 more classes in this area
Blood & clotting
10.3%Factor Xa inhibitor10.3%Xarelto54%Eliquis46%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update
Journal of Clinical Oncology
2026 - Supportive oncology and the USA Cancer Moonshot: academic, clinical and operational opportunities
BMJ Supportive & Palliative Care
2026 - Nutritional Interventions in Advanced Cancer: Scoping Review
American Journal of Hospice and Palliative Medicine®
2025 - Age and muscle measures predict benefit of surgery in locally-advanced adenocarcinoma of the esophagus
Surgical Oncology Insight
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David Herrington, MD
Atrium Health Wake Forest Baptist
Bruce Lessey, MD
Atrium Health Wake Forest Baptist
David Hurd, MD
Atrium Health Wake Forest Baptist
Kevin High, MD
Atrium Health Wake Forest Baptist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”